504 related articles for article (PubMed ID: 6889533)
1. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
[TBL] [Abstract][Full Text] [Related]
2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
4. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
5. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
[TBL] [Abstract][Full Text] [Related]
7. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
Morgenstern R; Fink H
J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
[TBL] [Abstract][Full Text] [Related]
8. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
Schremmer C; Morgenstern R; Fink H; Ott T
Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
[TBL] [Abstract][Full Text] [Related]
9. Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.
Dall'Olio R; Roncada P; Vaccheri A; Gandolfi O; Montanaro N
Psychopharmacology (Berl); 1989; 98(3):342-6. PubMed ID: 2568655
[TBL] [Abstract][Full Text] [Related]
10. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
11. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
Pich EM; Samanin R
Psychopharmacology (Berl); 1986; 89(1):125-30. PubMed ID: 2874581
[TBL] [Abstract][Full Text] [Related]
12. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
Smith RC; Davis JM
Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
[TBL] [Abstract][Full Text] [Related]
13. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
[TBL] [Abstract][Full Text] [Related]
14. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
15. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
17. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
Gordon JH; Clopton JK; Curtin JC; Koller WC
Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
[TBL] [Abstract][Full Text] [Related]
18. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
Fink H; Morgenstern R
Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
20. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
Radhakishun FS; Van Ree JM
Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
